Announcements Trials

Browse Landscape

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Conditions

Lymphoma, Large B-Cell, Diffuse 8 Sarcoma 5 Neoplasms 4 Lymphoma, Non-Hodgkin 4 Immunoproliferative Disorders 3 Recurrence 2 Osteosarcoma 2 Neoplasm Metastasis 2 Lymphoproliferative Disorders 2 Lymphoma, Follicular 2 Lymphoma, B-Cell 2 Lymphoma 2 Lymphatic Diseases 2 Hematologic Diseases 2 Sarcoma, Synovial 1 Sarcoma, Endometrial Stromal 1 Precursor Cell Lymphoblastic Leukemia-Lymphoma 1 Neurofibrosarcoma 1 Neuroblastoma 1 Neoplasms by Histologic Type 1 Liposarcoma 1 Leiomyosarcoma 1 Immune System Diseases 1 Histiocytoma, Malignant Fibrous 1 Hemangiosarcoma 1 Fibrosarcoma 1 Desmoplastic Small Round Cell Tumor 1 Carcinoma, Renal Cell 1 Bone Neoplasms 1 B-Cell Malignancies 1

Interventions

Nivolumab 19 Ipilimumab 9 linrodostat 6 relatlimab 4 Pemetrexed 4 Paclitaxel 4 Carboplatin 4 ARRY-334543 4 Docetaxel 3 regorafenib 2 anlotinib 2 abemaciclib 2 N-(3,4-difluoro-2-(2-fluoro-4-iodophenylamino)-6-methoxyphenyl)-1-(2,3-dihydroxypropyl)cyclopropane-1-sulfonamide 2 Gemcitabine 2 Cyclophosphamide 2 Capecitabine 2 6-(6-(1-methyl-1H-pyrazol-4-yl)-(1,2,4)triazolo(4,3-b)pyridazin-3-ylsulfanyl)quinoline 2 vorolanib 1 trametinib 1 tislelizumab 1 sargramostim 1 ralimetinib 1 prexasertib 1 palifosfamide lysine 1 p38 Mitogen-Activated Protein Kinases 1 mirdametinib 1 lirilumab 1 indibulin 1 gedatolisib 1 fluzoparib 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

INDUSTRY × Advanced Cancer × Ifosfamide × Clear all

NCT00607711 2008-05-05

Study of Oral Palifosfamide Tris in Solid Tumors

Alaunos Therapeutics

Phase 1 Suspended

Advanced Cancer

Data powered by HemOnc (CC BY 4.0) Colophon ⚡